Skip to main content
. Author manuscript; available in PMC: 2014 Dec 10.
Published in final edited form as: Clin Cancer Res. 2010 Apr 6;16(8):2466–2473. doi: 10.1158/1078-0432.CCR-09-3015

Table 1.

Baseline demographics

Dose level 1
(6 mg/m2), n (%)		 Dose level 2
(7.5 mg/m2), n (%)
Total 34 9
Gender
  Male 17 (50) 2 (22.2)
  Female 17 (50) 7 (77.8)
Age (y), mean (range) 58.8 (36–80) 55.1 (50–64)
ECOG at screen
  0 15 (44.1) 3 (33.3)
  1 17 (50.0) 6 (66.7)
  2 1 (2.9) 0
  Unknown 1 (2.9) 0
Cancer type
  Adenocarcinoma 16 (47.1) 3 (33.3)
  Squamous 5 (14.7) 1 (11.1)
  Large cell 1 (2.9) 1 (11.1)
  NOS 11 (32.4) 4 (44.4)
  Mixed 1* (2.9) 0

Abbreviation: NOS, not otherwise specified.

*

Squamous and adenocarcinoma.